The prevalence of obesity and diabetes mellitus (DM) has been consistently increasing
worldwide. Sharing powerful genetic and environmental features in their pathogenesis …

The absorption of oral drugs is frequently plagued by significant variability with potentially
serious therapeutic consequences. The source of variability can be traced back to …

China has one of the largest populations with obesity in the world, and obesity has become
a major challenge for the country's health-care system. Current guidelines for obesity …

Non-alcoholic fatty liver disease (NAFLD) is a series of diseases, involving excessive lipid
deposition in the liver and is often accompanied by obesity, diabetes, dyslipidemia …

Obesity continues to be among the top health concerns across the globe. Despite our failure
to contain the high prevalence of obesity, we now have a better understanding of its …

Non-alcoholic fatty liver disease (NAFLD) is to date the most common chronic liver disease
in clinical practice and, consequently, a major health problem worldwide. It affects …

Obesity is a chronic, progressive and relapsing disease with a rising global prevalence
associated with increased morbidity and mortality and reduced quality of life. Treatment of …

Background: The World Health Organization (WHO) classifies malnutrition as the biggest
threat to public health worldwide, and this condition is observed in 20–60% of hospitalized …

Polysaccharides are known to confer protection against obesity via modulation of gut
microbiota. To expand our knowledge of mushroom-derived prebiotics, we investigated the …

Background & Aims Bariatric surgery is the most successful treatment for obesity. However,
many patients avoid surgery due to its perceived invasive nature and fear of complications …